Ningbo Menovo Pharmaceutical Co., Ltd. provided earnings guidance for the full year of 2019. According to preliminary statistics of its financial department, the Company predicts that the net profit belonging to shareholders of the listed company in 2019 will be between RMB 140,000,000 and RMB 154,000,000 with an increase of between RMB 43,650,000 and RMB 57,650,000 and an increase of between 45% and 60% compared with the same period of the year before; the net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss in 2019 will be between RMB 125,000,000 and RMB 141,000,000 with an increase of between RMB 65,190,000 and RMB8 1,190,000 and an increase of between 109% and 136% compared with the same period of the year before.